155 related articles for article (PubMed ID: 10943527)
1. Respiratory syncytial virus infections in immunocompromised adults.
Whimbey E; Ghosh S
Curr Clin Top Infect Dis; 2000; 20():232-55. PubMed ID: 10943527
[TBL] [Abstract][Full Text] [Related]
2. Respiratory syncytial virus and parainfluenza virus infections in the immunocompromised host.
Wendt CH; Hertz MI
Semin Respir Infect; 1995 Dec; 10(4):224-31. PubMed ID: 8668850
[TBL] [Abstract][Full Text] [Related]
3. Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin.
Ghosh S; Champlin RE; Englund J; Giralt SA; Rolston K; Raad I; Jacobson K; Neumann J; Ippoliti C; Mallik S; Whimbey E
Bone Marrow Transplant; 2000 Apr; 25(7):751-5. PubMed ID: 10745261
[TBL] [Abstract][Full Text] [Related]
4. Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients.
Whimbey E; Champlin RE; Englund JA; Mirza NQ; Piedra PA; Goodrich JM; Przepiorka D; Luna MA; Morice RC; Neumann JL
Bone Marrow Transplant; 1995 Sep; 16(3):393-9. PubMed ID: 8535312
[TBL] [Abstract][Full Text] [Related]
5. Respiratory syncytial virus pneumonitis in immunocompromised adults: clinical features and outcome.
Ebbert JO; Limper AH
Respiration; 2005; 72(3):263-9. PubMed ID: 15942295
[TBL] [Abstract][Full Text] [Related]
6. Respiratory syncytial virus immune globulin treatment of lower respiratory tract infection in pediatric patients undergoing bone marrow transplantation - a compassionate use experience.
DeVincenzo JP; Hirsch RL; Fuentes RJ; Top FH
Bone Marrow Transplant; 2000 Jan; 25(2):161-5. PubMed ID: 10673674
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of respiratory syncytial virus infections in immunocompromised hematological patients].
Thorsen S; Hornsleth AK; Pedersen BK; Heilmann CJ
Ugeskr Laeger; 2000 Aug; 162(35):4644-7. PubMed ID: 10986889
[TBL] [Abstract][Full Text] [Related]
8. Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients.
Chávez-Bueno S; Mejías A; Merryman RA; Ahmad N; Jafri HS; Ramilo O
Pediatr Infect Dis J; 2007 Dec; 26(12):1089-93. PubMed ID: 18043443
[TBL] [Abstract][Full Text] [Related]
9. Viral pneumonia in the immunocompromised adult with neoplastic disease: the role of common community respiratory viruses.
Whimbey E; Bodey GP
Semin Respir Infect; 1992 Jun; 7(2):122-31. PubMed ID: 1332171
[TBL] [Abstract][Full Text] [Related]
10. Treatment of respiratory syncytial virus pneumonia in a lung transplant recipient: case report and review of the literature.
Flynn JD; Akers WS; Jones M; Stevkovic N; Waid T; Mullett T; Jahania S
Pharmacotherapy; 2004 Jul; 24(7):932-8. PubMed ID: 15303457
[TBL] [Abstract][Full Text] [Related]
11. Respiratory syncytial virus infection in adults.
Murata Y
Curr Opin Pulm Med; 2008 May; 14(3):235-40. PubMed ID: 18427247
[TBL] [Abstract][Full Text] [Related]
12. Pre-emptive oral ribavirin therapy of paramyxovirus infections after haematopoietic stem cell transplantation: a pilot study.
Chakrabarti S; Collingham KE; Holder K; Fegan CD; Osman H; Milligan DW
Bone Marrow Transplant; 2001 Oct; 28(8):759-63. PubMed ID: 11781627
[TBL] [Abstract][Full Text] [Related]
13. Respiratory syncytial virus infection in patients with hematological diseases: single-center study and review of the literature.
Khanna N; Widmer AF; Decker M; Steffen I; Halter J; Heim D; Weisser M; Gratwohl A; Fluckiger U; Hirsch HH
Clin Infect Dis; 2008 Feb; 46(3):402-12. PubMed ID: 18181739
[TBL] [Abstract][Full Text] [Related]
14. Respiratory syncytial virus infection in adults.
Falsey AR
Semin Respir Crit Care Med; 2007 Apr; 28(2):171-81. PubMed ID: 17458771
[TBL] [Abstract][Full Text] [Related]
15. Prevention and treatment of respiratory syncytial virus infections (for advances in pediatric infectious diseases).
DeVincenzo J
Adv Pediatr Infect Dis; 1997; 13():1-47. PubMed ID: 9544306
[No Abstract] [Full Text] [Related]
16. Respiratory syncytial virus infection in adult BMT recipients: effective therapy with short duration nebulised ribavirin.
McColl MD; Corser RB; Bremner J; Chopra R
Bone Marrow Transplant; 1998 Feb; 21(4):423-5. PubMed ID: 9509980
[TBL] [Abstract][Full Text] [Related]
17. Intravenous ribavirin is a safe and cost-effective treatment for respiratory syncytial virus infection after lung transplantation.
Glanville AR; Scott AI; Morton JM; Aboyoun CL; Plit ML; Carter IW; Malouf MA
J Heart Lung Transplant; 2005 Dec; 24(12):2114-9. PubMed ID: 16364859
[TBL] [Abstract][Full Text] [Related]
18. Respiratory syncytial virus persistence in chronic obstructive pulmonary disease.
Sikkel MB; Quint JK; Mallia P; Wedzicha JA; Johnston SL
Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S63-70. PubMed ID: 18820581
[TBL] [Abstract][Full Text] [Related]
19. [Respiratory syncytial virus infections: measures in immunocompromised patients].
Hirsch HH; Steffen I; Francioli P; Widmer AF
Praxis (Bern 1994); 2006 Jan; 95(3):61-6. PubMed ID: 16459735
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy of respiratory syncytial virus pneumonia following bone marrow transplantation.
De Vincenzo JP; Leombruno D; Soiffer RJ; Siber GR
Bone Marrow Transplant; 1996 Jun; 17(6):1051-6. PubMed ID: 8807113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
